Axcelis Technologies, Inc. designs, manufactures and services the ion implantation and other processing equipment used in the manufacture of semiconductor chips in the United States, Europe and Asia. The company is headquartered in Beverly, Massachusetts.
| Revenue (TTM) | $839.05M |
| Gross Profit (TTM) | $376.85M |
| EBITDA | $129.23M |
| Operating Margin | 15.20% |
| Return on Equity | 11.70% |
| Return on Assets | 5.50% |
| Revenue/Share (TTM) | $26.57 |
| Book Value | $33.68 |
| Price-to-Book | 2.82 |
| Price-to-Sales (TTM) | 3.57 |
| EV/Revenue | 3.083 |
| EV/EBITDA | 16.04 |
| Quarterly Earnings Growth (YoY) | -28.30% |
| Quarterly Revenue Growth (YoY) | -5.60% |
| Shares Outstanding | $30.73M |
| Float | $30.52M |
| % Insiders | 0.62% |
| % Institutions | 106.76% |